Start-up in Thailand discusses how it's developing a plant-based Covid vaccine
Dr. Suthira Taychakhoonavudh of Baiya Phytopharm discusses the progress the company has made on clinical trials for what could be Thailand's first plant-based Covid vaccine.
UP NEXT
NOW PLAYING: Today
Start-up in Thailand discusses how it's developing a plant-based Covid vaccine
CNBC
UP NEXT
-
I'm looking at value over growth, and cyclicals will continue to outperform, says Payne's Garcia
CNBC
-
Target's backend was a disaster, says Hightower's Stephanie Link
-
This is the year of the Fed, says Requisite's Bryn Talkington
-
Block is no longer a payments company, CEO Jack Dorsey says at company's investor day
-
'Investors are getting worried about consumer demand,' says Bernstein's Sacconaghi
-
Fintech becomes second biggest group in CNBC Disruptor 50 list
-
Disruptor 50: How Exotec is using robotics to help fix the global supply chain and labor shortage
-
Yellen: We want the maximum negatuve impact on Russia
-
The Late Morning Rundown: May 18, 2022
-
Businesses need to build in a margin of safety, says Lightspeed's Alex Taussig
-
Google is the most insulated of all the mega-cap technology stocks, says Evercore's Mahaney
-
Steady gas demand will be another element for bull market in oil to feed on, says Again Capital's Kilduff
-
Target will have a couple quarters of working through inventory, says Cowen's Oliver Chen
-
We don't see a whole lot of downside from the levels where Apple is trading, says Evercore's Daryanani
-
Jim Cramer on his biggest investing regret
-
Inflation pressures may be easing more rapidly than the Fed expected, says Schwab’s Kleintop
